Angiotensin-(1-9) reverses experimental hypertension and cardiovascular damage by inhibition of the angiotensin converting enzyme/Ang II axis
Artículo
Open/ Download
Publication date
2014Metadata
Show full item record
Cómo citar
Ocaranza, Maria Paz
Cómo citar
Angiotensin-(1-9) reverses experimental hypertension and cardiovascular damage by inhibition of the angiotensin converting enzyme/Ang II axis
Author
- Ocaranza, Maria Paz;
- Moya, Jackeline;
- Barrientos, Victor;
- Alzamora, Rodrigo;
- Hevia, Daniel;
- Morales, Cristobal;
- Pinto, Melissa;
- Escudero, Nicolás;
- García Nannig, Lorena;
- Novoa, Ulises;
- Ayala, Pedro;
- Díaz Araya, Guillermo;
- Godoy, Ivan;
- Chiong Lay, Mario;
- Lavandero González, Sergio;
- Jalil Milad, Jorge;
Abstract
BACKGROUND:: Little is known about the biological effects of angiotensin-(1-9), but available evidence shows that angiotensin-(1-9) has beneficial effects in preventing/ameliorating cardiovascular remodeling. OBJECTIVE:: In this study, we evaluated whether angiotensin-(1-9) decreases hypertension and reverses experimental cardiovascular damage in the rat. METHODS AND RESULTS:: Angiotensin-(1-9) (600 ng/kg per min for 2 weeks) reduced already-established hypertension in rats with early high blood pressure induced by angiotensin II infusion or renal artery clipping. Angiotensin-(1-9) also improved cardiac (assessed by echocardiography) and endothelial function in small-diameter mesenteric arteries, cardiac and aortic wall hypertrophy, fibrosis, oxidative stress, collagen and transforming growth factor type β - 1 protein expression (assessed by western blot). The beneficial effect of angiotensin-(1-9) was blunted by coadministration of the angiotensin type 2(AT2) receptor blocker PD123319
Indexation
Artículo de publicación SCOPUS
Identifier
URI: https://repositorio.uchile.cl/handle/2250/158312
DOI: 10.1097/HJH.0000000000000094
ISSN: 14735598
02636352
Quote Item
Journal of Hypertension, Volumen 32, Issue 4, 2018, Pages 771-783
Collections
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile
Related items
Showing items related by title, author, creator and subject.
-
Westermeier, Francisco; Bustamante, Mario; Pavez, Mario; García Nannig, Lorena; Chiong Lay, Mario; Ocaranza, María Paz; Lavandero González, Sergio (Elsevier, 2015)Insulin-like growth factor-1, angiotensin-(1-7) and angiotensin-(1-9) have been proposed to be important mediators in cardioprotection. A large body of evidence indicates that insulin like growth factor-1 has pleotropic ...
-
Presence of angiotensin II and expression of angiotensin II type-2 receptor in human fallopian tube Johnson, M. Cecilia; Castro, Andrea; Troncoso, José Luis; Vantman, David; Devoto, Luigi; Vega Blanco, María Margarita (1998)Objective: To determine the presence of angiotensin II and angiotensin II type-2 receptor subtype messenger RNA (mRNA) in human fallopian tube. Design: Frozen fallopian tubes were used for all studies. Setting: Procedures ...
-
Jalil Milad, Jorge; Piddo, Ana María; Cordova, Samuel; Chamorro, Gastón; Braun, Sandra; Jalil, Roberto; Vega, Jeanette; Jadue, Liliana; Lavandero González, Sergio; Lastra, Patricia (1999)The aim of this study was to estimate the prevalence of the different alleles of the angiotensin converting enzyme (ACE) gene insertion/deletion (I/D) polymorphism and associated plasma ACE activity, as well as cardiac ...